Insufficient scRNA-seq data for expression of DIABLO at single-cell level.
Insufficient scRNA-seq data for expression of DIABLO at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1022.91 | 258 / 258 | 60% | 2.73 | 139 / 230 |
brain | 100% | 846.14 | 2642 / 2642 | 51% | 0.75 | 359 / 705 |
ovary | 100% | 840.78 | 180 / 180 | 43% | 0.68 | 185 / 430 |
esophagus | 100% | 698.00 | 1445 / 1445 | 22% | 0.31 | 41 / 183 |
skin | 100% | 871.70 | 1809 / 1809 | 17% | 0.24 | 82 / 472 |
lung | 100% | 720.12 | 578 / 578 | 14% | 0.25 | 163 / 1155 |
bladder | 100% | 842.14 | 21 / 21 | 10% | 0.17 | 51 / 504 |
uterus | 100% | 766.26 | 170 / 170 | 9% | 0.15 | 43 / 459 |
kidney | 100% | 887.04 | 89 / 89 | 9% | 0.15 | 83 / 901 |
stomach | 100% | 656.55 | 359 / 359 | 7% | 0.14 | 21 / 286 |
breast | 100% | 855.40 | 459 / 459 | 7% | 0.12 | 78 / 1118 |
intestine | 100% | 904.36 | 966 / 966 | 5% | 0.09 | 25 / 527 |
thymus | 100% | 872.76 | 653 / 653 | 3% | 0.04 | 19 / 605 |
pancreas | 100% | 431.97 | 327 / 328 | 3% | 0.07 | 6 / 178 |
prostate | 100% | 762.22 | 245 / 245 | 2% | 0.06 | 11 / 502 |
adipose | 100% | 765.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 843.88 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 750.07 | 241 / 241 | 0% | 0 | 0 / 0 |
liver | 100% | 525.09 | 225 / 226 | 0% | 0.00 | 1 / 406 |
muscle | 100% | 588.45 | 800 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 653.92 | 905 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 542.82 | 831 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.22 | 5 / 29 |
eye | 0% | 0 | 0 / 0 | 11% | 0.14 | 9 / 80 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008635 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
GO_0006915 | Biological process | apoptotic process |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_0008631 | Biological process | intrinsic apoptotic signaling pathway in response to oxidative stress |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0035631 | Cellular component | CD40 receptor complex |
GO_0005829 | Cellular component | cytosol |
GO_0005739 | Cellular component | mitochondrion |
GO_0005515 | Molecular function | protein binding |
Gene name | DIABLO |
Protein name | Direct IAP-binding protein with low pI (Second mitochondria-derived activator of caspase) Diablo IAP-binding mitochondrial protein (Diablo homolog, mitochondrial) (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase) (Smac) [Cleaved into: Diablo IAP-binding mitochondrial protein, cleaved form] Diablo IAP-binding mitochondrial protein |
Synonyms | hCG_1782202 SMAC |
Description | FUNCTION: Promotes apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway. Acts by opposing the inhibitory activity of inhibitor of apoptosis proteins (IAP). Inhibits the activity of BIRC6/bruce by inhibiting its binding to caspases. .; FUNCTION: [Isoform 3]: Attenuates the stability and apoptosis-inhibiting activity of XIAP/BIRC4 by promoting XIAP/BIRC4 ubiquitination and degradation through the ubiquitin-proteasome pathway. Also disrupts XIAP/BIRC4 interacting with processed caspase-9 and promotes caspase-3 activation. .; FUNCTION: [Isoform 1]: Defective in the capacity to down-regulate the XIAP/BIRC4 abundance. . |
Accessions | H7BZQ7 Q9NR28 ENST00000541273.6 A0A2R8Y5H2 ENST00000342392.3 ENST00000353548.11 [Q9NR28-3] A0A2U3TZH2 ENST00000443649.9 F5GYH3 ENST00000439489.6 ENST00000650715.1 [Q9NR28-1] ENST00000541656.6 F5GXT8 F5GX50 ENST00000267169.11 ENST00000644227.1 ENST00000446652.5 Q502X2 ENST00000540535.6 A0A024RBT2 A0A0S2Z5U7 A0A0S2Z5P6 H7BZK7 ENST00000464942.7 [Q9NR28-1] K7X1S0 |